Source BioScience

Hurry, time’s running out! ⏰ For October only, get 25% bonus vouchers on our rapid whole plasmid sequencing! Use these vouchers with Nanopore 30 for whole plasmid sequencing and get results in as fast as 12 hours*. Don’t miss this chance to accelerate your research while saving big! Learn more about our rapid plasmid sequencing service here 👉 https://lnkd.in/eMXH7VXQ #Genomics #OxfordNanopore #DNA #Sequencing #Nanopore #Genome #DNA #TheSequencingPeople

Join us for the last two CONEXEN events of 2024! 🚨 Don’t miss out the exclusive life sciences, biopharma and health tech networking opportunities: 📅 21 November 2024 - Oxford : https://lnkd.in/e87rnR_7 📅 11 December 2024 - Cambridge: https://lnkd.in/eNrjbPXj Whether you're in healthtech, biopharma, life sciences, academia, or VC, these events are tailored to help you build a network for success. 🌟 Pre-Register now at conexen.net and be part of our growing community. #CONEXEN #healthcare #biotech #biotechnology #ventures #venturecapital #biopharma #healthtech #pharmaceuticals #pharma #executives #networking #lifesciences #London #Cambridge #Oxford #goldentriangle

Digital advancements are reshaping healthcare, with AI and cutting-edge technologies revolutionising diagnostic delivery. Source LDPath boosts diagnostic capacity for NHS and private healthcare, helping to reduce pathology backlogs across the UK. With a full suite of services—from histopathology to molecular diagnostics—we harness digital pathology, AI, and the expertise of 280+ Consultant Pathologists to deliver timely, quality care. Andrew Wilson, Service Manager at Bradford Teaching Hospitals NHS Foundation Trust, shares insights on the hospital’s digitisation journey and Source LDPath’s role in enhancing speed and precision in diagnostics. Read the full article here 👉 https://lnkd.in/esCHztTc #Healthcare #Pathology #PatientCare #Histopathology #PrivateHealthcare #NHS #CellularPathology #DigitalPathology #PathologyServices #BiomedicalScience #PathologyNews

Digital advancements are reshaping healthcare and the way diagnoses are delivered., with cutting-edge technologies and AI solutions leading the charge. At the forefront of this revolution Source BioScience, comprising Source LDPath and Source Genomics, is a global leader in histopathology and genomics services. Source LDPath supports both NHS and private healthcare in the UK by expanding reporting capacity and addressing pathology sample backlogs. Offering a full range of services, from histopathology to molecular diagnostics, it leverages digital pathology, AI, and a network of over 250 expert Consultant Pathologists to ensure top-quality patient care. To gain a deeper understanding of how these advancements are making their mark, we spoke with Andrew Wilson, Service Manager at Bradford Teaching Hospitals NHS Foundation Trust. In this insightful conversation, Andrew shares his journey from finance to pathology management and discusses how Bradford’s digitization process is unfolding, with Source LDPath playing a pivotal role. From cutting down turnaround times to harnessing AI for complex diagnoses, Andrew paints a picture of a future where technology and human expertise work hand-in-hand to deliver faster, more accurate patient care. You can read the conversation in fill using the link below. 🔗 https://lnkd.in/gEv6Vjqw #digitalpathology #pathologynews

Source LDPath: A Histopathology Partnership for Coroners 🔬 At Source LDPath, we offer industry-leading, end-to-end histopathology services designed to support coroners at every step. From digital pathology and AI to molecular diagnostics, our expert team ensures high-quality results with market-leading turnaround times. Here’s how we can help: ✔️ Rely on our expert Biomedical Scientists for efficient sample processing ✔️ Benefit from fast, reliable sample returns for swift reporting ✔️ Experience clear communication between our laboratory and your team ✔️ Enjoy a seamless sample transportation process with our trusted courier network. Discover how to partner with us for industry-leading cellular pathology services 👉https://lnkd.in/e7c3pZAx #Healthcare #Pathology #PatientCare #Histopathology #PrivateHealthcare #NHS #CellularPathology #DigitalPathology #PathologyServices #Coroners #BiomedicalScience

No trick! Treat yourself to 10% EXTRA off your genomics testing today! 🧬 Over 300 universities and research organisations trust Source Genomics for their sequencing solutions—now it’s your turn! Claim an exclusive 10% extra discount on our services and discover why we’re the go-to choice for Sanger sequencing, NGS, proteomics, and more. Learn more or contact our Genomics team here 👉 https://lnkd.in/g--2yN_T #Genomics #SangerSequencing #NGS #Proteomics #Biomarkers #BiomarkerDiscovery #DrugDiscovery #Multiomics #LifeScience #TheSequencingPeople

🚨 New blog post alert! 🚨 Discover how digital pathology is revolutionising diagnostics, enhancing accuracy, efficiency, and collaboration across healthcare. This game-changing technology is shaping the future of patient care, medical research, and the training of tomorrow’s pathologists. Read "What Are The Benefits Of Digital Pathology?" here 👉 https://lnkd.in/eUdm-Z4G #Healthcare #Pathology #PatientCare #MedicalResearch #Diagnostics #Healthcare #Histopathology #PrivateHealthcare #NHS #CellularPathology #DigitalPathology #AI

The Science Behind the MAF Test®: Advancing Beyond Traditional Guidelines The MAF Test® leverages advanced biomarker analysis to predict bone metastasis risk and guide treatment decisions in early breast cancer patients. While current ESMO/ASCO guidelines typically stratify patients based on menopausal status, the MAF Test® provides new, personalized and more precise insights that go beyond these traditional methods. By identifying which patients are likely to benefit from bisphosphonates, regardless of menopausal status or other clinicopathological variance, the MAF Test® supports more precise and effective treatment plans. For more information: https://lnkd.in/eiMDrfR5 #Oncology #BreastCancer #Biomarkers #PersonalizedMedicine

🌶 Hot off the press! Source BioScience recently Headline Sponsored our NHS Pathology Conferences and here are a few words from the team based on their experience with us. Interested in Exhibiting an event? Take a look at our sponsorship page below and contact us 👇 https://loom.ly/v1cUt38 Check out our upcoming events here - https://loom.ly/suYXF_g

Receive an exclusive 25% off with Source Genomics on Olink Explore 3k, Explore HT and Target 48/96 proteomics assays* 📣 Maximise the power of proteomics, an innovative technology for highly sensitive and robust protein analysis, providing high-throughput and scalable biomarker discovery for your project with unparalleled specificity. Get in touch with us today to take advantage of this limited time offer 👉https://lnkd.in/ewzmta34 #Genomics #SangerSequencing #NGS #Biomarkers #Olink #Proteomics #BiomarkerDiscovery #DrugDiscovery #Multiomics #Genome #LifeScience #DNA #TheSequencingPeople *Terms and Conditions: Explore 384 not included. Purchase order must be placed and data returned by end of 2024. Find out more here or contact us for further information.